4.4 Article

Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema

Marc Figueras-Roca et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2019)

Article Ophthalmology

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro

Marina Mesquida et al.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2019)

Article Ophthalmology

Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema

Marc Figueras-Roca et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

Review Ophthalmology

Roles of IL-6 in Ocular Inflammation: A Review

Hassan Ghasemi

OCULAR IMMUNOLOGY AND INFLAMMATION (2018)

Editorial Material Ophthalmology

Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy

Laura R. Steeples et al.

INTERNATIONAL OPHTHALMOLOGY (2018)

Review Ophthalmology

Mechanisms of macular edema: Beyond the surface

Alejandra Daruich et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2018)

Article Ophthalmology

INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema

R. Lejoyeux et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2018)

Article Ophthalmology

Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach

Stela Vujosevic et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Article Medicine, General & Internal

Adalimumab in Patients with Active Noninfectious Uveitis

Glenn J. Jaffe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Ophthalmology

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets

Arup Das et al.

OPHTHALMOLOGY (2015)

Article Endocrinology & Metabolism

Classification of diabetic retinopathy and diabetic macular edema

Lihteh Wu et al.

WORLD JOURNAL OF DIABETES (2013)

Article Endocrinology & Metabolism

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W. Y. Yau et al.

DIABETES CARE (2012)

Article Ophthalmology

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

Usha Chakravarthy et al.

OPHTHALMOLOGY (2012)

Review Ophthalmology

Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets

Sampathkumar Rangasamy et al.

MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY (2012)

Review Ophthalmology

Roles of IL-8 in Ocular Inflammations: A Review

Hassan Ghasemi et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2011)

Article Endocrinology & Metabolism

TNF-α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients

Carin Gustavsson et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2008)

Article Ophthalmology

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis - A pilot study

Friederike Mackensen et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)

Article Ophthalmology

Impact of macular edema on visual acuity in uveitis

Charlotte W. T. A. Lardenoye et al.

OPHTHALMOLOGY (2006)

Editorial Material Ophthalmology

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

DA Jabs et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)

Article Endocrinology & Metabolism

Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids

J Mysliwiec et al.

HORMONE AND METABOLIC RESEARCH (2001)